Journal of Visceral Surgery最新文献

{"title":"Laparoscopic enucleation of an endocrine tumor of the pancreatic uncus (with video)","authors":"Augustin Suffisseau , Renato Micelli Lupinacci","doi":"10.1016/j.jviscsurg.2026.02.003","DOIUrl":"10.1016/j.jviscsurg.2026.02.003","url":null,"abstract":"","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":"163 3","pages":"Pages 230-231"},"PeriodicalIF":2.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147436953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Beyond recurrence: Late relapses and second primary tumors after curative esophagectomy","authors":"Aurore Protat ,&nbsp;Julie Veziant ,&nbsp;Clarisse Eveno ,&nbsp;Marguerite Messier ,&nbsp;Sebastien Degisors ,&nbsp;Guillaume Piessen ,&nbsp;Thibault Voron","doi":"10.1016/j.jviscsurg.2026.01.007","DOIUrl":"10.1016/j.jviscsurg.2026.01.007","url":null,"abstract":"<div><h3>Introduction</h3><div>The majority of recurrences after esophagectomy occur within the first two years. In France, postoperative follow-up usually continues for five years. However, later relapses have been reported, raising the question of whether prolonged follow-up is indicated.</div></div><div><h3>Methods</h3><div>A retrospective, two-center study was conducted at the University Hospital of Lille and Saint-Antoine Hospital in Paris. The study included patients who had undergone curative esophageal cancer surgery between 2009 and 2015, and were alive and free of recurrence at five years. Late recurrences (≥<!--> <!-->5 years) and second primary cancers were identified and their associated factors analyzed.</div></div><div><h3>Results</h3><div>Of 664 patients who underwent resection of esophageal cancer, 229 met the inclusion criteria. Twelve of these patients (5.2%) experienced a late recurrence, 50% of which were metastatic, occurring up to 107 months after surgery. In multivariable analysis, five variables were independently associated with decreased recurrence-free survival: male sex (OR<!--> <!-->=<!--> <!-->6.09; <em>P</em> <!-->=<!--> <!-->0.001), prior cancer history (OR<!--> <!-->=<!--> <!-->2.28; <em>P</em> <!-->=<!--> <!-->0.048), neoadjuvant chemoradiotherapy (OR<!--> <!-->=<!--> <!-->3.18; <em>P</em> <!-->=<!--> <!-->0.002), squamous cell carcinoma (OR<!--> <!-->=<!--> <!-->2.22; <em>P</em> <!-->=<!--> <!-->0.022), and positive-margin resections (OR<!--> <!-->=<!--> <!-->56.32; <em>P</em> <!-->=<!--> <!-->0.001). Sixteen patients (6.9%) developed a second primary cancer, mainly head and neck or lung cancer. Neoadjuvant chemoradiotherapy was associated with an increased risk of a second cancer site (OR<!--> <!-->=<!--> <!-->2.64; <em>P</em> <!-->=<!--> <!-->0.011).</div></div><div><h3>Conclusion</h3><div>A residual risk of disease progression persists beyond five years after curative esophagectomy, in the form of late recurrences (5%) and second primary cancers (6.9%). These findings challenge the systematic discontinuation of follow-up at five years and support a prolonged and individualized surveillance strategy.</div></div>","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":"163 3","pages":"Pages 174-182"},"PeriodicalIF":2.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147366987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Right ileocoloplasty for the management of caustic esophageal stricture (with video)","authors":"Samuel Dos Santos ,&nbsp;Pierre Cattan ,&nbsp;Hélène Corté","doi":"10.1016/j.jviscsurg.2026.02.007","DOIUrl":"10.1016/j.jviscsurg.2026.02.007","url":null,"abstract":"","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":"163 3","pages":"Pages 235-236"},"PeriodicalIF":2.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147370662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pancreatic portal fistula: A rare complication following pancreatectomy","authors":"Maxime Constant ,&nbsp;Paul Calame ,&nbsp;Teddy Deregnaucourt ,&nbsp;Alexandre Doussot","doi":"10.1016/j.jviscsurg.2026.03.003","DOIUrl":"10.1016/j.jviscsurg.2026.03.003","url":null,"abstract":"","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":"163 3","pages":"Pages 228-229"},"PeriodicalIF":2.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147534061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"RE: “Gastric volumetry: A simplified calculation method based on CT-scan”","authors":"Amit Kumar Gupta ,&nbsp;Chandrashekar Patil ,&nbsp;Jeffrin Reneus Paul","doi":"10.1016/j.jviscsurg.2026.03.001","DOIUrl":"10.1016/j.jviscsurg.2026.03.001","url":null,"abstract":"","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":"163 3","pages":"Pages 237-238"},"PeriodicalIF":2.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147533996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparative accuracy of Boey score and PULP score for predicting prognosis in patients with perforated peptic ulcer: A systematic review and meta-analysis","authors":"Abraham Gita Ramanda Christanto ,&nbsp;Albertus Ari Adrianto","doi":"10.1016/j.jviscsurg.2026.02.010","DOIUrl":"10.1016/j.jviscsurg.2026.02.010","url":null,"abstract":"<div><h3>Aim of the study</h3><div>Boey and peptic ulcer perforation (PULP) scores are two scoring systems frequently employed to forecast prognosis in patients with perforated peptic ulcer (PPU). Unfortunately, which of these two scoring systems has better performance is still questionable. This study seeks to compare the accuracy of Boey and PULP scores in forecasting mortality and morbidity among patients with PPU.</div></div><div><h3>Patients and methods</h3><div>A thorough search was performed on the Cochrane Library, Scopus, Medline, and Google Scholar databases until April 10th, 2025, employing a combination of pertinent keywords. This review incorporates literature that examines the performance of Boey or PULP scores for PPU. A meta-analysis was conducted to assess the prognostic accuracy of both scoring systems for predicting mortality and morbidity utilizing a bivariate random-effects model.</div></div><div><h3>Results</h3><div>A total of thirty-six studies were incorporated. Our meta-analysis findings suggest that, although not statistically significant, the PULP score demonstrated comparatively higher pooled sensitivity (80% vs. 78%), specificity (85% vs. 78%), and diagnostic odds ratio (20.67 vs. 12.69) than the Boey score for predicting mortality in perforated peptic ulcer (PPU) patients. For morbidity prediction, the PULP score also yielded marginally better sensitivity (62% vs. 54%) and a comparable specificity (85% vs. 86%) relative to the Boey score.</div></div><div><h3>Conclusions</h3><div>This analysis indicates that the PULP and Boey scores show comparable accuracy in predicting both mortality and morbidity in patients with PPU, supporting the use of either tool for clinical risk assessment in this setting.</div></div>","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":"163 3","pages":"Pages 164-173"},"PeriodicalIF":2.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147787271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"“Kindness is not a profession”: A reflection on the importance of soft skills in surgical training","authors":"Morgane Bouquot","doi":"10.1016/j.jviscsurg.2026.02.009","DOIUrl":"10.1016/j.jviscsurg.2026.02.009","url":null,"abstract":"","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":"163 3","pages":"Pages 161-163"},"PeriodicalIF":2.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147444755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Goodbye P < 0.05. P-value is simply one item among many to gauge scientific evidence","authors":"Karem Slim ,&nbsp;Chadli Dziri ,&nbsp;Bob Occean","doi":"10.1016/j.jviscsurg.2026.02.005","DOIUrl":"10.1016/j.jviscsurg.2026.02.005","url":null,"abstract":"<div><div>For a century <em>P</em>-value is routinely used in almost every research paper with a threshold of 0.05 to reject the null hypothesis. The aim of this short review was to discuss the validity of this arbitrary (yet sacred) threshold. The history of <em>P</em>-value shows that very quickly, practitioners had found a simple method that appealed to them, while statisticians saw no great need to curb this enthusiasm, which seemed consensual. However, heavy reliance on <em>P</em>-values is of concern because of potential misuse and misinterpretation. The main pitfalls of <em>P</em> <!-->&lt;<!--> <!-->0.05 are the dichotomized approach with a black-or-white judgement, possible false positive results, lack of information about magnitude of the effect, clinical relevance, and use out of context. These pitfalls explain why several statisticians and researcher recommend abandoning, not the <em>P</em>-value itself but the threshold of 0.05 and the term “statistical significance”. We are faced with a paradigm shift by demoting <em>P</em>-value from its threshold-screening role and using alternative tools such as Bayesian methods, effect size with confidence intervals, more stringent thresholds, pragmatic trials, and the minimal clinically important difference. This will require statisticians, researchers, publishers, and health care decision makers to radically change the way they interpret scientific data by abandoning century-old dichotomous analysis–a true revolution to come.</div></div>","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":"163 3","pages":"Pages 190-194"},"PeriodicalIF":2.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147311785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal and gastric peritoneal metastases: Where are we today?","authors":"Diane Goéré,&nbsp;Clément Pastier","doi":"10.1016/j.jviscsurg.2025.12.001","DOIUrl":"10.1016/j.jviscsurg.2025.12.001","url":null,"abstract":"<div><div>Peritoneal metastases originating from colorectal cancer (CRPM) and gastric cancer (GCPT) occur frequently (metachronous in 15 to 40% of patients) and are most often diagnosed at an advanced stage because symptoms are sparse at the initial stages of disease. Abdominal-pelvic computed tomography with or without arterial and portal phase evaluation is essential for the diagnosis of recurrence or peritoneal involvement. However, exploration of the peritoneal cavity by laparoscopy can confirm the diagnosis and provide histological evidence. It is crucial to distinguish between palliative and potentially curative treatments; the latter based on complete resection of disease, the feasibility of which depends on technical, oncological and physiological criteria. The treatment of CRPM and GCPM is based on systemic chemotherapy (associated with or without targeted therapy) potentially combined with complete cytoreductive surgery (CRS) in selected patients and performed in expert centers. The survival benefit of CRS in patients with CRPM has been validated with a median survival of 41 months (PRODIGE 7). Regarding the addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to CRS, mitomycin C is the preferred drug used and a phase-3 randomized trial comparing CRS plus HIPEC to mitomycin C versus CRS alone, is underway in Spain. Regarding GCPM, survival results after CRS, after CRS plus HIPEC, or after systemic chemotherapy alone, remain disappointing. The goal of CONVERGENCE, an international trial (starting soon in France), will be to evaluate the benefit of CRS in these patients. The prognosis of colorectal and gastric peritoneal disease (PD) has improved substantially in recent decades, thanks to better knowledge of these entities, managed surgically and oncologically in expert reference centers. The potential benefits of HIPEC in combination with CRS are under evaluation in randomized trials.</div></div>","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":"163 3","pages":"Pages 195-208"},"PeriodicalIF":2.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145994553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"How to manage pelvic-perineal necrotic bacterial dermohypodermitis.","authors":"Alexandra Pellegrin, Charles Sabbagh, Jean-Marc Regimbeau, Octave Charvillat, Rodolphe Chartier, Arnaud Alves","doi":"10.1016/j.jviscsurg.2026.03.006","DOIUrl":"https://doi.org/10.1016/j.jviscsurg.2026.03.006","url":null,"abstract":"<p><p>Pelvic-perineal necrotic bacterial dermohypodermitis, also known as Fournier's gangrene, is a rare infection, at 1.6/100,000, affecting males in more than 95% of cases, frequently overwhelming and with very poor prognosis. It is polymicrobial in more than 80% of cases, spreading rapidly in the subcutaneous perineal tissue due to bacterial enzymes. Recent mortality estimates were between 7.5 and 20%. The main risk factors, related to impairment of immunity and microcirculation, include diabetes, smoking and alcohol abuse, obesity, HIV infection, cardiac, renal and/or hepatic comorbidity, and cancer. Diagnosis is primarily clinical. Presentation typically associates fever, intense pain, scrotal edema, cutaneous erythema and subcutaneous crepitation, with possible rapid progression to septic shock. Prognostic scores have been developed, but their use should never delay implementation of abdominal-pelvic CT and surgery. Debridement needs to be carried out early, within 12hours of symptom onset; mortality is increased 3-fold if the delay exceeds 14hours: 24 versus 69%. Management is sequential and multidisciplinary, associating hemodynamic stabilization, broad-spectrum probabilistic antibiotic therapy, and iterative \"skin-sparing\" debridement, which improves the rate of delayed primary closure (7 vs. 38%; P=0.002) and hospital stay (26 vs. 46 days; P=0.02), and facilitates secondary reconstruction.</p>","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147822828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}